CLINICAL_TRIALS
trial_result
· 2020-10-14
Clinical Trial Update: Dose-Response Study of MDMA-assisted Psychotherapy in People With PTSD [Phase 2]
Summary
Phase 2 dose-response study investigating MDMA-assisted psychotherapy for PTSD has completed and posted results in 2020.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Lykos Therapeutics | Conditions: Posttraumatic Stress Disorder | Phase 2 | Status: COMPLETED | Results posted: 2020-10-14